Ann Brody Guy
  • Home
  • Portfolio
    • Editing
    • Writing
    • Multimedia Projects
  • Kudos
  • About
  • Contact
  • Fresh Ink!

Fresh Ink!​

Will the New Vaccines Be Safe?

12/11/2020

 
Picture
Don't we all want to know? UCSF Magazine had me ask experts for a personal take on vaccine safety, encompassing  a variety of perspectives from the university's medical and health schools and research centers. Despite numerous updates that delayed publication as vaccine news changed daily, the story went live in a sweet spot in the news cycle,  just on the cusp of the FDA's Emergency Use Approval for the first U.S. vaccine. 

"Two months [of safety data from a broad population] is not unreasonable for people who have the highest risk of COVID-19 exposure and the lowest risk of adverse vaccine reactions – people who have more to gain from a vaccine – such as primary care providers and first responders. If I were in this group, I would say, “OK, two months will do for me.” 
​
But for people at lower risk of contracting COVID-19 – those who can work from home, for example – but at higher risk of medical complications, then I think when to get vaccinated becomes a personal decision. They may want to wait until we accumulate more information from longer follow-up times – perhaps six months from the start of the phase III trials." Read more.



Comments are closed.

    Fresh Ink! is a blog showcasing recent work by Ann Brody Guy, an Oakland-based freelance writer-editor covering science, health, and higher education

    Categories

    All

    RSS Feed

Proudly powered by Weebly
  • Home
  • Portfolio
    • Editing
    • Writing
    • Multimedia Projects
  • Kudos
  • About
  • Contact
  • Fresh Ink!